Anthera Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	2008 - 2012
Period Ending	Jan '26 Jan 8, 2026	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	2008 - 2012
Market Capitalization	0	23	27	185	36	59	Upgrade
Market Cap Growth	-99.66%	-16.09%	-85.28%	410.48%	-38.84%	20.82%	Upgrade
Enterprise Value	-	17	8	129	29	46	Upgrade
Last Close Price	0.00	1.65	5.19	37.12	12.64	24.56	Upgrade
PS Ratio	-	-	187.81	58.09	-	-	Upgrade
PB Ratio	0.00	-4.16	2.12	4.67	-16.03	4.02	Upgrade
P/TBV Ratio	0.00	-	7.06	4.67	-	4.02	Upgrade
EV/Sales Ratio	-	-	54.52	40.58	-	-	Upgrade
Debt / Equity Ratio	-	-	-	-	-	1.21	Upgrade
Asset Turnover	-	-	0.00	0.12	-	-	Upgrade
Quick Ratio	3.06	0.47	1.96	5.58	0.46	3.43	Upgrade
Current Ratio	3.30	0.68	2.14	5.65	0.53	3.48	Upgrade
Return on Equity (ROE)	-568.85%	-731.07%	-211.50%	-188.36%	-473.78%	-549.52%	Upgrade
Return on Assets (ROA)	-141.96%	-167.77%	-99.83%	-85.35%	-86.96%	-55.29%	Upgrade
Return on Capital (ROIC)	-559.32%	-619.42%	-136.13%	-117.80%	-117.13%	-71.10%	Upgrade
Return on Capital Employed (ROCE)	-596.90%	3509.80%	-445.10%	-88.90%	1258.70%	-94.60%	Upgrade
Earnings Yield	-952291.83%	-117.60%	-203.88%	-19.04%	-81.68%	-52.07%	Upgrade
FCF Yield	-	-161.47%	-182.44%	-16.75%	-70.63%	-53.87%	Upgrade
Buyback Yield / Dilution	-152.23%	-99.05%	-15.94%	-63.62%	-19.21%	-152.82%	Upgrade

Updated May 15, 2018. Source: S&P Global Market Intelligence. Standard template. Financial Sources.